Navigation Links
The American Society for Microbiology honors Mario Santiago
Date:8/22/2012

The 2012 ICAAC Young Investigator Award designated for a researcher working in the area of HIV has been bestowed upon Mario L. Santiago, Ph.D., Division of Infectious Diseases, University of Colorado, Denver. Santiago is honored for his varied work in virology, from field-based HIV epidemiology studies to manipulating innate immunity in his efforts to explore innovative new ways to approach the challenge of the HIV vaccine. "Already at this early stage of his career, Santiago is demonstrating that he is one of the upcoming leaders in the field of retroviral resistance genes and their fascinating mechanisms of action," explains Kim Hasenkrug, Rocky Mountain Laboratories, NIAID.

Santiago graduated from the University of the Philippines magna cum laude with a BS in Molecular Biology and Biotechnology. He then worked on schistosome and malaria vaccines as part of the NIH-sponsored Tropical Medicine Research Center in the Philippines and on HIV-1 molecular epidemiology as a Fogarty AIDS International Research fellow at Brown University. Santiago went on to receive his Ph.D. in Microbiology under Beatrice Hahn at the University of Alabama-Birmingham, where he developed noninvasive methods to detect Simian Immunodeficiency Virus in wild nonhuman primates, eventually leading to the discovery of the origins of HIV-1 and HIV-2 in wild chimpanzees and sooty mangabeys, respectively. "During his tenure, he painstakingly designed, tested and optimized strategies to noninvasively screen fecal and urine samples from wild monkeys and great apes for simian immunodeficiency viruses, which aided in our breakthrough understanding of the origins of HIV-1 and HIV-2," explains Hahn. "These findings resulted in fascinating high-profile publications and have revolutionized our perspective on the AIDS pandemic."

After receiving his Ph.D., Santiago completed two postdoctoral fellowships, first at the University of Alabama-Birmingham, then at the Gladstone Institute for Virology and Immunology at the University of California, San Francisco, where he discovered that a long-sought classical resistance gene that modulates the retrovirus-specific neutralizing antibody response known as Rfv3 corresponds to an innate immunity gene known as APOBEC3. In 2006, Santiago reached out to Hasenkrug to collaborate: "he emailed me with the hypothesis that a retroviral resistance gene that I had mapped (Rfv3), might be Apobec3. He trained briefly in my lab, learned the mouse retrovirus model very quickly, and in short order had the model working at the Gladstone Institute. He has pushed this research forward, innovating new techniques and technologies, and has opened the door to a very exciting and highly competitive research area."

In 2009, Santiago joined the Division of Infectious Diseases at the University of Colorado Denver-Anschutz Medical Campus. There he continues his work on the interplay between innate retroviral restriction and adaptive immunity in mice, monkeys and humans, with a conceptual focus on HIV vaccine development, host genetics of retrovirus resistance, and interferon-based antiretroviral therapy. He currently supervises a post-doctoral fellow and three graduate students from the Immunology and Microbiology programs, where he holds adjunct appointments.

Santiago's scientific contributions have been published in prominent journals that include Science, Nature, Cell, PNAS, PLoS Pathogens, and The Journal of Virology. "Santiago's recent work on the function of human Apobec3 has helped delineate potential genetic mechanisms behind the production of neutralizing antibodies to HIV, which are critical to preventing HIV infection," says nominator Thomas Campbell, University of Colorado, Denver. "His research findings will help to inform the discovery of HIV drugs and vaccines." He concludes, "Santiago's outstanding achievements attest to his creativity and collegiality, and his exceptional ability to successfully accomplish innovative, cutting-edge research in retrovirology."
'/>"/>

Contact: Garth Hogan
ghogan@asmusa.org
American Society for Microbiology
Source:Eurekalert

Related biology news :

1. The American Society for Microbiology honors David Tobin
2. North American freshwater fishes race to extinction
3. MARC travel awards announced for the 2012 American Society of Human Genetics Annual Meeting
4. 2012 American Chestnut Summit
5. Study reveals impact of historical domestic cattle hybridization with American bison
6. Chemistry on Mars video with Curiosity Rover from the American Chemical Society
7. American Health Assistance Foundation announces grants to advance promising vision research
8. Levels of hepatitis C virus higher among African-Americans and males
9. American Society for Microbiologys newest journal earns a high impact factor in latest rankings
10. Looking for the next American hyrax?
11. Investigation of American Oriental Bioengineering, Inc. by Securities Lawyers at Goldfarb LLP Law Firm for Potential Shareholder Claim
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... According to a new market research report "Emotion Detection and Recognition Market ... Application Area, End User, And Region - Global Forecast to 2021", published by ... 2016 to USD 36.07 Billion by 2021, at a Compound Annual Growth Rate ... ... MarketsandMarkets Logo ...
(Date:12/6/2016)... Valencell , the leading innovator in ... a third consecutive year of triple digit growth for ... with a 360 percent increase in companies who have ... driven by sales of its wrist and ear Benchmark™ ... technology for hearables for fitness and healthcare applications. ...
(Date:11/30/2016)... Nov. 30, 2016 Not many of us realize that we spend ? ... so we need to do it well. Inadequate sleep levels have been found to ... stroke, diabetes, and even cancer. Maybe now is the best time to ... help them to manage their sleep quality? Continue Reading ... ...
Breaking Biology News(10 mins):
(Date:12/8/2016)...  OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ... immunotherapies, today announced financial results for the fiscal ... delivering on our commitment to address an unmet ... are pleased with the early clinical response data ... are focused on advancing our lead program – ...
(Date:12/8/2016)... 2016 AskLinkerReports.com has published a report ... Amyloglucosidase Industry 2016 Market Research Report. From a basic outline ... overview are all covered in the report. This report projects ... analysis of the Amyloglucosidase industry. ... , , ...
(Date:12/8/2016)... , Dec. 8, 2016  Renova™ Therapeutics, a ... heart failure and type 2 diabetes, announced that ... novel adeno-associated virus (AAV) vector developed in the ... Ph.D., at Stanford University. The company plans to ... gene therapy product pipeline. "Early ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... cells — optogenetics — is key to exciting advances in the study and ... patterned light projected via free-space optics stimulates small, transparent organisms and excites neurons ...
Breaking Biology Technology: